These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8799515)

  • 1. Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients.
    Bullingham R; Shah J; Goldblum R; Schiff M
    Br J Clin Pharmacol; 1996 Jun; 41(6):513-6. PubMed ID: 8799515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
    Bullingham R; Monroe S; Nicholls A; Hale M
    J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
    Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
    Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
    MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
    Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers.
    Wong SL; Linnen P; Mack R; Granneman GR
    Biopharm Drug Dispos; 1997 Aug; 18(6):533-41. PubMed ID: 9267685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
    Johnson HJ; Swan SK; Heim-Duthoy KL; Nicholls AJ; Tsina I; Tarnowski T
    Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.
    Gimenez F; Foeillet E; Bourdon O; Weller S; Garret C; Bidault R; Singlas E
    Clin Pharmacokinet; 2004; 43(10):685-92. PubMed ID: 15244498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel bioavailability: absence of influence of food or antacids.
    McEwen J; Strauch G; Perles P; Pritchard G; Moreland TE; Necciari J; Dickinson JP
    Semin Thromb Hemost; 1999; 25 Suppl 2():47-50. PubMed ID: 10440423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
    Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.
    Hummel M; Yonan N; Ross H; Miller LW; Sechaud R; Balez S; Koelle EU; Gerosa G;
    Clin Transplant; 2007; 21(1):18-23. PubMed ID: 17302587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.
    Tedesco-Silva H; Bastien MC; Choi L; Felipe C; Campestrini J; Picard F; Schmouder R
    Transplant Proc; 2005 Mar; 37(2):852-5. PubMed ID: 15848554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysis.
    Morgera S; Neumayer HH; Fritsche L; Kuchinke S; Lampe D; Ahnert V; Bauer S; Mai I; Budde K
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):159-63. PubMed ID: 9562232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.
    Ling J; Shi J; Jiang Q; Jiao Z
    Eur J Clin Pharmacol; 2015 Jan; 71(1):95-106. PubMed ID: 25327506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
    Liang MZ; Lu YP; Nan F; Li YP
    Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.
    Shaw LM; Mick R; Nowak I; Korecka M; Brayman KL
    J Clin Pharmacol; 1998 Mar; 38(3):268-75. PubMed ID: 9549665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.